DIA Biosimilars 2013

CROs/Service Providers

Trudeau Institute launches nonprofit CRO

Friday, March 16, 2012 05:00 PM

The Trudeau Institute, a Saranac Lake, N.Y.-based research center, has expanded the scope of its biomedical research by creating a nonprofit CRO, the Trudeau Institute Contract Research Organization (TICRO).

More... »

Cenduit: Now with Patient Reminders

Marken inaugurates new branches in India

Friday, March 16, 2012 11:08 AM

Marken continues their expansion of services in India by augmenting their existing Mumbai facility with four additional branches in New Delhi, Hyderabad, Pune and Bangalore.

More... »

CRF Health – eCOA Forum

AstraZeneca, BioFocus, Argenta collaborate on respiratory and inflammatory diseases

Thursday, March 15, 2012 06:02 AM

Galapagos’ service companies, BioFocus and Argenta, have entered into a multi-year collaboration agreement with AstraZeneca to find new compounds against key targets in respiratory and inflammatory diseases.

More... »

Delcath selects Quintiles to support EU launch of Chemosat

Wednesday, March 14, 2012 04:47 PM

Delcath Systems, an ongology-focused pharmaceutical company, has selected Quintiles to provide a specialized team of Medical Science Liaisons (MSLs) to support the launch of the Hepatic Chemosat Delivery System for the treatment of cancers in the liver in France, Germany, Italy, Netherlands, Spain, Ireland and the U.K. 

More... »

inVentiv's iHCE establishes headquarters in London

Wednesday, March 14, 2012 11:01 AM

Switzerland-based inVentiv Health Communications/Europe (iHCE), an inVentiv Health company, is opening its new operational headquarters in London to serve as a hub for all European offices and support the rapid growth of the company’s consolidated communications business.

More... »

SIRO Clinpharm names Gopakumar Menon CEO

Thursday, March 8, 2012 12:37 PM

Mumbai, India-based CRO SIRO Clinpharm has named Gopakumar Menon CEO.

More... »

inVentiv Health launches multichannel marketing company MySTRO

Thursday, March 8, 2012 12:34 PM

Burlington, Mass.-based inVentiv Health, which provides clinical, commercial and consulting services to the healthcare industry, has launched MySTRO, a multichannel marketing and sales solutions company. MySTRO provides sales force support, telephone and remote personal selling, print and direct mail, sample accountability and compliance services.

More... »

AmerisourceBergen to acquire World Courier

Thursday, March 8, 2012 12:31 PM

AmerisourceBergen has agreed to purchase World Courier Group, a privately held global specialty transportation and logistics provider for the biopharmaceutical industry, for $520 million in cash.

More... »

ASLAN selects PharmaNet/i3 as strategic partner for oncology development

Tuesday, March 6, 2012 01:30 PM

ASLAN Pharmaceuticals has selected PharmaNet/i3, inVentiv Health’s clinical segment, as a strategic partner supporting the development of its oncology portfolio in Asia and conducting phase I and phase II clinical trials for two of ASLAN’s compounds.

More... »

ICON, Roche in technology partnership

Tuesday, March 6, 2012 01:27 PM

Global CRO ICON has been selected by Roche as its technology partner for storing and managing medical images collected during the company’s clinical research programs.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs